封面
市場調查報告書
商品編碼
1741265

沙門氏菌檢測市場:依檢測方法、依樣本種類、依應用、依最終使用者、按地區

Salmonella Testing Market, By Testing Method, By Sample Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

沙門氏菌檢測市場規模預計在 2025 年為 36.4 億美元,預計到 2032 年將達到 61.6 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 7.8%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 36.4億美元
效能數據 2020-2024 預測期 2025-2032
預測期:2025-2032年年複合成長率: 7.80% 2032年價值預測 61.6億美元

沙門氏菌屬是一類會導致人類全身性疾病(非傷寒沙門氏菌病)的細菌,也是全球食源性疾病的主要原因之一。沙門氏菌具有複雜的生理機能,能夠利用多種營養來源,並在各種環境中生存。沙門氏菌也能夠利用複雜的毒力機制適應環境壓力並克服免疫反應。

市場動態

沙門氏菌引起的食源性疾病是全球食物中毒的常見原因。沙門氏菌疫情的增加引發了公眾對健康的擔憂,推動了對沙門氏菌檢測的需求。快速且準確的檢測對於識別受污染食品、啟動必要的召回以及進一步阻止疾病傳播至關重要。

對於食品公司來說,實施沙門氏菌檢測通訊協定和維護檢測設施的成本非常高昂,尤其對於中小型企業 (SME) 而言。試劑、檢測用品和合格人員的前期成本可能很高。維護和更新檢測系統以及遵守法規相關的持續成本可能會限制全面實施沙門氏菌檢測計畫。

本研究的主要特點

  • 本報告對全球沙門氏菌檢測市場進行了詳細分析,並提供了市場規模和預測期年複合成長率(CAGR%)(假設 2024 年為基準年)。
  • 它還強調了各個領域的潛在收益成長機會,並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數,概述了全球沙門氏菌檢測市場的主要企業。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球沙門氏菌檢測市場報告迎合了該行業的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員將透過用於分析全球沙門氏菌檢測市場的各種策略矩陣來做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
  • 沙門氏菌感染疾病發生率增加
    • 限制因素
  • 沙門氏菌檢測高成本
    • 機會
  • 拓展新興市場
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

4. 沙門氏菌檢測市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 沙門氏菌檢測市場(依檢測方法分類),2020 年至 2032 年

  • 基於文化
  • 分子基礎
  • 免疫檢測

6. 2020 年至 2032 年沙門氏菌檢測市場(依樣本類型)

  • 食物
  • 環境表面

7. 沙門氏菌檢測市場(按應用分類),2020 年至 2032 年

  • 臨床診斷
  • 食品安全檢測
  • 獸醫診斷

8. 沙門氏菌檢測市場(以最終用戶分類),2020 年至 2032 年

  • 食品生產商和製造商
  • 合約檢驗機構
  • 政府和監管機構

9. 沙門氏菌檢測市場(按地區分類),2020 年至 2032 年

  • 北美洲
      • 美國
      • 加拿大
  • 歐洲
      • 英國
      • 德國
      • 義大利
      • 法國
      • 西班牙
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • 澳洲
      • 韓國
      • ASEAN
      • 其他亞太地區
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 中東
      • 海灣合作理事會國家
      • 以色列
      • 其他中東地區
  • 非洲
      • 北非
      • 南非
      • 中部非洲

第10章 競爭格局

  • Thermo Fisher Scientific
  • Vitrosens Biotechnology
  • Merck KGaA
  • bioMerieux SA
  • Neogen Corporation
  • QIAGEN NV
  • 3M
  • PerkinElmer Inc.
  • Romer Labs Division Holding GmbH
  • Eurofins Scientific
  • Hardy Diagnostics
  • Charles River Laboratories
  • LabCorp
  • R-Biopharm AG
  • Biomerica, Inc.

第 11 章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6013

Salmonella Testing Market is estimated to be valued at USD 3.64 Bn in 2025 and is expected to reach USD 6.16 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3.64 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.80% 2032 Value Projection: USD 6.16 Bn

The genus Salmonella is a group of bacteria that causes human systemic disease (non-typhoid salmonellosis), and they are one of the leading causes of foodborne illness in the world. They are able to survive in different environments because of their complex physiology that allows them to use various nutrient sources. Salmonella is also able to adapt to environmental stresses and can overcome immune responses by using sophisticated virulence mechanisms.

Market Dynamics

All around the world, foodborne diseases are frequently caused by salmonella. The demand for Salmonella testing is being driven by the increase in Salmonella outbreaks, which is causing public health concerns. In order to identify contaminated food products, launch necessary recalls, and stop the spread of illnesses further, quick and precise testing is essential.

It can be expensive for food companies to implement testing protocols for salmonella and to maintain testing facilities, especially for small and medium-sized businesses (SMEs). Initial costs for reagents, testing tools, and qualified employees might be high. The implementation of thorough Salmonella testing programs can be constrained by the continuing costs related to maintaining and updating testing systems and complying with regulatory regulations.

Key Features of the Study:

  • This report provides an in-depth analysis of the global salmonella testing market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global salmonella testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific, Vitrosens Biotechnology, Merck KGaA, bioMerieux SA, Neogen Corporation, QIAGEN N.V., 3M, PerkinElmer Inc., Romer Labs Division Holding GmbH, Eurofins Scientific, Hardy Diagnostics, Charles River Laboratories, LabCorp, R-Biopharm AG, and Biomerica Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global salmonella testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global salmonella testing market

Detailed Segmentation:

  • By Testing Method:
    • Culture-based Methods
    • Molecular-based Methods
    • Immunoassays
  • By Sample Type:
    • Food
    • Water
    • Environmental Surfaces
  • By Application:
    • Clinical Diagnostics
    • Food Safety Testing
    • Veterinary Diagnostics
  • By End User:
    • Food Producers and Manufacturers
    • Contract Testing Laboratories
    • Government and Regulatory Bodies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Thermo Fisher Scientific
    • Vitrosens Biotechnology
    • Merck KGaA
    • bioMerieux SA
    • Neogen Corporation
    • QIAGEN N.V.
    • 3M
    • PerkinElmer Inc.
    • Romer Labs Division Holding GmbH
    • Eurofins Scientific
    • Hardy Diagnostics
    • Charles River Laboratories
    • LabCorp
    • R-Biopharm AG
    • Biomerica, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Salmonella Testing, By Testing Method
    • Market Salmonella Testing, By Sample Type
    • Market Salmonella Testing, By Application
    • Market Salmonella Testing, By End User
    • Market Salmonella Testing, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing Incidence of Salmonella Outbreaks
    • Restraints
  • High Costs of Salmonella Testing
    • Opportunities
  • Expansion in Emerging Markets
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Salmonella Testing Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Salmonella Testing Market, By Testing Method, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Culture-based Methods
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Molecular-based Methods
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Immunoassays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Salmonella Testing Market, By Sample Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Food
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Water
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Environmental Surfaces
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Salmonella Testing Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Clinical Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Food Safety Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Veterinary Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Salmonella Testing Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Food Producers and Manufacturers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Contract Testing Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Government and Regulatory Bodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Salmonella Testing Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
      • North Africa
      • South Africa
      • Central Africa

10. Competitive Landscape

  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vitrosens Biotechnology
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • bioMerieux SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Neogen Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • QIAGEN N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • 3M
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • PerkinElmer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Romer Labs Division Holding GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Eurofins Scientific
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Hardy Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Charles River Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • LabCorp
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • R-Biopharm AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biomerica, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us